Gastrointestinal benefits of probiotics—clinical evidence

Lactic Acid Bacteria: Microbiological and Functional Aspects, Fourth Edition

Volumn , Issue , 2011, Pages 509-523

  Lyra, Anna ^a   Lahtinen, Sampo ^a   Ouwehand, Arthur C ^a  

^a Health and Nutrition   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BOWEL FUNCTIONS; CLINICAL CONDITIONS; CLINICAL INTERVENTIONS; GASTROINTESTINAL; HEALTH EFFECTS; HOST IMMUNE RESPONSE; IMMUNE FUNCTION; INTERVENTION STUDIES;

PROBIOTICS;

EID: 84939929745     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (105)

1. Agrawal, A., L. A. Houghton, J. Morris, et al. 2008. Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 29:104-114.
2. Allen, S. J., E. G. Martinez, G. V. Gregorio, and L. F. Dans. 2010. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 11:CD003048.
3. Allen, S. J., B. Okoko, E. Martinez, G. Gregorio, and L.F. Dans. 2004. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2:CD003048.
4. Arciero, J. C., G. B. Ermentrout, J. S. Upperman, Y. Vodovotz, and J. E. Rubin. 2010. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS One 5:e10066.
5. Armuzzi, A., F. Cremonini, F. Bartolozzi, et al. 2001. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15:163-169.
6. Beaugerie, L., A. Flahault, F. Barbut et al. 2003. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 17:905-912.
7. Bekkali, N., M. E. Bongers, M. M. Van den Berg, O. Liem, and M. A. Benninga. 2007. The role of a probiotics mixture in the treatment of childhood constipation: A pilot study. Nutr J 6:17.
8. Boutron, M.C., J. Faivre, P. Marteau, C. Couillault, P. Senesse, and V. Quipourt. 1996. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: A French case-control study. Br J Cancer 74:145-151.
9. Braegger, C.P. 2010. Probiotics and the prevention of necrotizing enterocolitis. Ann Nutr Metab 57 Suppl:14-15.
10. Canducci, F., A. Armuzzi, F. Cremonini, et al. 2000. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14:1625-1629.
11. Candy, D.C., Densham, L., Lamont, L.S., et al. 2001. Effect of administration of Lactobacillus casei Shirota on sodium balance in an infant with short bowel syndrome. J Pediatr Gastroenterol Nutr 32:506-508.
12. Chmielewska, A. and H. Szajewska. 2010. Systematic review of randomised controlled trials: Probiotics for functional constipation. World J Gastroenterol 16:69-75.
13. Cindoruk, M., G. Erkan, T. Karakan, A. Dursun, and S. Unal. 2007. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study. Helicobacter 12:309-316.
14. Crawford, P.A. and J. I. Gordon. 2005. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci U S A 102:13254-13259.
15. Cremonini, F., S. Di Caro, M. Covino, et al. 2002. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744-2749.
16. Davis, C.D. and J. A. Milner. 2009. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 20:743-752.
17. De La Cochetiere, M.F., T. Durand, V. Lalande, J. C. Petit, G. Potel, and L. Beaugerie. 2008. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol 56:395-402.
18. de Roos, N.M. and M. B. Katan. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998. Am J Clin Nutr 71:405-411.
19. de Vrese, M., A. Stegelmann, B. Richter, S. Fenselau, C. Laue, and J. Schrezenmeir. 2001. Probiotics— Compensation for lactase insufficiency. Am J Clin Nutr 73:421S-429S.
20. Dendukuri, N. and J. Brophy. 2007. Inappropriate use of meta-analysis to estimate efficacy of probiotics. Am J Gastroenterol 102:201-204.
21. Deshpande, G., S. Rao, S. Patole, and M. Bulsara. 2010. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921-930.
22. Dethlefsen, L., S. Huse, M. L. Sogin, and D. A. Relman. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280.
23. Doherty, G., G. Bennett, S. Patil, A. Cheifetz, and A. C. Moss. 2009. Interventions for prevention of postoperative recurrence of Crohn’s disease. Cochrane Database Syst Rev 4:CD006873.
24. Doherty, G. A., G. C. Bennett, A. S. Cheifetz, and A. C. Moss. 2010. Meta-analysis: Targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol Ther 31:802-809.
25. Elahi, B., S. Nikfar, S. Derakhshani, M. Vafaie, and M. Abdollahi. 2008. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: A meta-analysis of controlled clinical trials. Dig Dis Sci 53:1278-1284.
26. Enck, P., K. Zimmermann, G. Menke, and S. Klosterhalfen. 2009. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z Gastroenterol 47:209-214.
27. Enck, P., K. Zimmermann, G. Menke, S. Muller-Lissner, U. Martens, and S. Klosterhalfen. 2008. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 20:1103-1109.
28. Friswell, M., B. Campbell, and J. Rhodes. 2010. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver 4:295-306.
29. Fuccio, L., A. Guido, L. H. Eusebi, et al. 2009. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol 43:506-513.
30. Gionchetti, P., C. Amadini, F. Rizzello et al. 2002. Probiotics—Role in inflammatory bowel disease. Dig Liver Dis 34(Suppl 2):S58-S62.
31. Goldin, B.R. and S. L. Gorbach. 1984. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39:756-761.
32. Goldman, C.G., D. A. Barrado, N. Balcarce, et al. 2006. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 22:984-988.
33. Guarino, A., F. Albano, S. Ashkenazi, et al. 2008. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Executive summary. J Pediatr Gastroenterol Nutr 46:619-621.
34. Guslandi, M., G. Mezzi, M. Sorghi, and P. A. Testoni. 1997. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 45:1462-1464.
35. Heaton, K. W., J. Radvan, H. Cripps, R. A. Mountford, F. E. Braddon, and A. O. Hughes. 1992. Defecation frequency and timing, and stool form in the general population: A prospective study. Gut 33:818-824.
36. Henrich, T.J., D. Krakower, A. Bitton, and D. S. Yokoe. 2009. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 15:415-422.
37. Hertzler, S.R. and S. M. Clancy. 2003. Kefir improves lactose digestion and tolerance in adults with lactose maldigestion. J Am Diet Assoc 103:582-587.
38. Hickson, M., A. L. D’Souza, N. Muthu et al. 2007. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial. BMJ 335:80.
39. Hoesl, C.E. and J. E. Altwein. 2005. The probiotic approach: An alternative treatment option in urology. Eur Urol 47:288-296.
40. Holma, R., S. M. Hongisto, M. Saxelin, and R. Korpela. 2010. Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects. J Nutr 140:534-541.
41. Holubar, S. D., R. R. Cima, W. J. Sandborn, and D. S. Pardi. 2010. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 6:CD001176.
42. Hoveyda, N., C. Heneghan, K. R. Mahtani, R. Perera, N. Roberts, and P. Glasziou. 2009. A systematic review and meta-analysis: Probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 9:15.
43. Hoyos, A.B. 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3:197-202.
44. Jiang, T., A. Mustapha, and D. A. Savaiano. 1996. Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum. J Dairy Sci 79:750-757.
45. Kajander, K., E. Myllyluoma, M. Rajilić-Stojanović, et al. 2008. Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 27:48-57.
46. Kale-Pradhan, P.B., H. K. Jassal, and S. M. Wilhelm. 2010. Role of Lactobacillus in the prevention of antibioticassociated diarrhea: A meta-analysis. Pharmacotherapy 30:119-126.
47. Kanamori, Y., K. Hashizume, M. Sugiyama, M. Morotomi, and N. Yuki. 2001. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: A novel synbiotics therapy for intestinal failure. Dig Dis Sci 46:2010-2016.
48. Kanamori, Y., M. Sugiyama, K. Hashizume, N. Yuki, M. Morotomi, and R. Tanaka. 2004. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 39:1686-1692.
49. Kolars, J. C., M. D. Levitt, M. Aouji, and D. A. Savaiano. 1984. Yogurt—An autodigesting source of lactose. N Engl J Med 310:1-3.
50. Kuhbacher, T., S. J. Ott, U. Helwig, et al. 2006. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55:833-841.
51. Kumar, M., A. Kumar, R. Nagpal, et al. 2010. Cancer-preventing attributes of probiotics: An update. Int J Food Sci Nutr 61:473-496.
52. Larsen, C. N., S. Nielsen, P. Kaestel, et al. 2006. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60:1284-1293.
53. Ling, W. H., R. Korpela, H. Mykkanen, S. Salminen, and O. Hanninen. 1994. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 124:18-23.
54. Longstreth, G. F., W. G. Thompson, W. D. Chey, L. A. Houghton, F. Mearin, and R. C. Spiller. 2006. Functional bowel disorders. Gastroenterology 130:1480-1491.
55. Lyra, A., L. Krogius-Kurikka, J. Nikkila, et al. 2010. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol 10:110.
56. Maclennan, R. and O. M. Jensen. 1977. Dietary fibre, transit-time, faecal bacteria, steroids, and colon cancer in two Scandinavian populations. Report from the International Agency for Research on Cancer Intestinal Microecology Group. Lancet 2:207-211.
57. Madden, J. A., S. F. Plummer, J. Tang, et al. 2005. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study. Int Immunopharmacol 5:1091-1097.
58. Malchow, H. A. 1997. Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J Clin Gastroenterol 25:653-658.
59. Mallon, P., D. McKay, S. Kirk, and K. Gardiner. 2007. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 4:CD005573.
60. Marteau, P., E. Cuillerier, S. Meance, et al. 2002. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study. Aliment Pharmacol Ther 16:587-593.
61. Marteau, P., P. Pochart, B. Flourie, et al. 1990. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52:685-688.
62. Martini, M. C., D. Kukielka, and D. A. Savaiano. 1991. Lactose digestion from yogurt: Influence of a meal and additional lactose. Am J Clin Nutr 53:1253-1258.
63. McFarland, L. V. 2007. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis 5:97-105.
64. McFarland, L. V. 2009. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 15:274-280.
65. Mendall, M. A. and D. Kumar. 1998. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 10:59-62.
66. Miele, E., F. Pascarella, E. Giannetti, L. Quaglietta, R. N. Baldassano, and Staiano. 2009. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 104:437-443.
67. Myllyluoma, E., T. Ahlroos, L. Veijola, H. Rautelin, S. Tynkkynen, and R. Korpela. 2007. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents 29:66-72.
68. Myllyluoma, E., L. Veijola, T. Ahlroos, et al. 2005. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy—A placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 21:1263-1272.
69. Olivares, M., M. A. Diaz-Ropero, N. Gomez, et al. 2006. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 107:104-111.
70. Ouwehand, A. C., H. Lagstrom, T. Suomalainen, and S. Salminen. 2002. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46:159-162.
71. Pitz, M., M. Cheang, and C. N. Bernstein. 2005. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 3:237-247.
72. Plummer, S. F., I. Garaiova, T. Sarvotham, et al. 2005. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents 26:69-74.
73. Preidis, G. A., C. Hill, R. L. Guerrant, B. S. Ramakrishna, G. W. Tannock, and J. Versalovic. 2011. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140:8-14.
74. Rafter, J. 2002. Lactic acid bacteria and cancer: Mechanistic perspective. Br J Nutr 88(Suppl 1):S89-S94.
75. Ringel, Y., T. Ringel-Kulka, D. Maier, et al. 2011. Probiotic bacteria: Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders—A double-blind study. J Clin Gastroenterol 45:518-552.
76. Rodriguez, L.A. and A. Ruigomez. 1999. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study. BMJ 318:565-566.
77. Ruszczynski, M., A. Radzikowski, and H. Szajewska. 2008. Clinical trial: Effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 28:154-161.
78. Sachdeva, A. and J. Nagpal. 2009. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: A systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 21:45-53.
79. Salminen, E., I. Elomaa, J. Minkkinen, H. Vapaatalo, and S. Salminen. 1988. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39:435-437.
80. Salminen, S. and E. Salminen. 1997. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol Suppl 222:45-48.
81. Salonen, A., W. M. de Vos, and A. Palva. 2010. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 156:3205-3215.
82. Sanders, M. E., D. C. Walker, K. M. Walker, K. Aoyama, and T. R. Klaenhammer. 1996. Performance of commercial cultures in fluid milk applications. J Dairy Sci 79:943-955.
83. Sang, L. X., B. Chang, W. L. Zhang, X. M. Wu, X. H. Li, and M. Jiang. 2010. Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J Gastroenterol 16:1908-1915.
84. Sazawal, S., G. Hiremath, U. Dhingra, P. Malik, S. Deb, and R. E. Black. 2006. Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6:374-382.
85. Schirbel, A. and C. Fiocchi. 2010. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 11:266-276.
86. Sentongo, T. A., V. Cohran, S. Korff, C. Sullivan, K. Iyer, and X. Zheng. 2008. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. J Pediatr Gastroenterol Nutr 46:41-47.
87. Shen, J., H. Z. Ran, M. H. Yin, T. X. Zhou, and D. S. Xiao. 2009. Meta-analysis: The effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease. Intern Med J 39:103-109.
88. Sheu, B.S., H. C. Cheng, A. W. Kao, et al. 2006. Pretreatment with Lactobacillus-and Bifidobacteriumcontaining yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 83:864-869.
89. Sheu, B. S., J. J. Wu, C. Y. Lo, et al. 2002. Impact of supplement with Lactobacillus-and Bifidobacteriumcontaining yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16: 1669-1675.
90. Sokol, H., P. Seksik, J. P. Furet, et al. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15:1183-1189.
91. Sood, A., V. Midha, G. K. Makharia, et al. 2009. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 7:1202-1209.
92. Spiller, R. C. and W. G. Thompson. 2010. Bowel disorders. Am J Gastroenterol 105:775-785.
93. Sykora, J., K. Valeckova, J. Amlerova, et al. 2005. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: A prospective randomized double-blind study. J Clin Gastroenterol 39:692-698.
94. Szajewska, H. and J. Z. Mrukowicz. 2001. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebocontrolled trials. J Pediatr Gastroenterol Nutr 33 Suppl 2:S17-25.
95. Tarnow-Mordi, W. O., D. Wilkinson, A. Trivedi, and J. Brok. 2010. Probiotics reduce all-cause mortality and necrotizing enterocolitis: It is time to change practice. Pediatrics 125:1068-1070.
96. Tursi, A., G. Brandimarte, G. M. Giorgetti, and M. E. Modeo. 2004. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 10:CR662-666.
97. Uchida, H., H. Yamamoto, Y. Kisaki, J. Fujino, Y. Ishimaru, and H. Ikeda. 2004. d-Lactic acidosis in shortbowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 39: 634-636.
98. van Goudoever, J. B., B. Koletzko, J. Rigo, W. Mihatsch, H. Szajewska, and R. Shamir. 2010. Authors’ Response. J Pediatr Gastroenterol Nutr 50:694-695.
99. Walker, A. W., J. D. Sanderson, C. Churcher, et al. 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11:7.
100. Waller, P. A., P. K. Gopal, G. J. Leyer, A. C. Ouwenaud, C. Reifer, M. E. Stewart, and L. E. Miller. 2011. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol, Early online, 1-8.
101. Willing, B. P., J. Dicksved, J. Halfvarson, et al. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844-1854.
102. Wollowski, I., G. Rechkemmer, and B. L. Pool-Zobel. 2001. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451S-455S.
103. Wolvers, D., J. M. Antoine, E. Myllyluoma, J. Schrezenmeir, H. Szajewska, and G. T. Rijkers. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of infections by probiotics. J Nutr 140:698S-712S.
104. Worthley, D. L., R. K. Le Leu, V. L. Whitehall, et al. 2009. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: Effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90:578-586.
105. Zou, J., J. Dong, and X. Yu. 2009. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 14:97-107.